logo-loader

NA Proactive news snapshot: Marrone Bio Innovations, ElectraMeccanica Vehicles, Silvercorp Metals, Universal mCloud UPDATE …

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Hemispherx Biopharma Inc - NA Proactive news snapshot: Hemispherx Biopharma, NexTech AR Solutions, Empower Clinics …
Your daily round-up from the world of Proactive

Marrone Bio Innovations Inc. (NASDAQ:MBII) delivered a news feast on Thursday, unveiling a transformative acquisition in the seed-and-soil-treatment market, together with a $36.6 million financing facility with existing investors, and posted strong second quarter results. The firm, an international leader in sustainable bioprotection and plant health solutions, has signed a definitive purchase agreement to acquire Pro Farm Technologies OY, a deal which will increase its market share and global platform in the $4.6 billion seed-and-soil-treatment market.

ElectraMeccanica Vehicles Corp (NASDAQ:SOLO) is speeding towards the full-scale launch of its SOLO electric vehicle, which could be a game-changer in the industry. Vancouver-based ElectraMeccanica, or simply Meccanica, updated shareholders on Thursday afternoon on a busy second quarter that saw the company reach a number of key milestones in its path to commercial vehicle production.

Silvercorp Metals Inc (CSE:SVM) (NSYEAMERICAN:SVM) saw a notable boost in the amount of silver, lead and zinc metals sold in its first quarter, the metals producer reported on Thursday.  The Vancouver-based company, which is focused on silver-related mineral properties in China, reported an increase of 27%, 20%, and 15%, respectively, in the amount of silver, lead, and zinc metals sold in the period, according to a statement by the firm.

Universal mCloud Corp. (CVE:MCLD) (OTCQB:MCLDF) has entered into a C$13 million credit facility with Integrated Private Debt Fund VI LP as part of a debt refinancing. In addition, the company said it intends to settle a debt owed to GBCC Corporation,  mCloud's advisor on Chinese market expansion opportunities with major building and wind turbine operations, in the amount of C$60,000 through the issuance of common shares of the company at a price per share to be determined by its board of directors.

Cannvas MedTech Inc. (CSE:MTEC) has changed its name to Eurolife Brands Inc. (CSE:EURO) and completed a four-for-one stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive three additional shares for each share held on such date. The shares will begin trading on a split basis - ex distribution - on August 14. Upon completion of the split, there will be approximately 348,204,444 shares issued and outstanding.

Agile Therapeutics, Inc. (NASDAQ:AGRX), the women’s healthcare company, said Thursday that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase an additional 1,894,736 shares of its common stock. The group said the additional shares were sold at the public offering price of $0.95 per share, before underwriting discounts and commissions. The closing occurred on August 8, 2019, bringing the total number of shares sold in the public offering to 14,526,315 and total gross proceeds to approximately $13.8 million.  The total net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $12.6 million from the offering.

Braingrid Limited (CSE:BGRD), a global provider of cultivation analytics using its affordable, scalable and easy-to-deploy sensor platforms for precision agriculture, said that, further to its press release dated June 18, 2019, European High Growth Opportunities Securitization Fund - advised by Alpha Blue Ocean Inc., - has converted $160,000 of its $850,000 aggregate principal amount of senior unsecured convertible debentures into 2,000,000 common shares of the company at an effective price of $0.08 per share. The group noted that the shares are subject to a hold period ending on October 15, 2019, being the date that is four months and one day following the date of issuance of the debentures. Under their agreement, Braingrid has a make whole obligation to the European High Growth Opportunities Securitization Fund of $84,200, payable either in shares or cash at the company's discretion, if cash the obligation would be netted against future debenture issuances.

Chanticleer Holdings Inc (NASDAQ:BURG) revealed Thursday that its franchise partner is opening a second Burgers Grilled Right (BGR) location in Kuwait.  In a statement, the Charlotte, North Carolina-based company said the most recent location is part of a 35-unit master franchise agreement covering four Gulf Coast countries.

VolitionRx Limited (NYSE:AMERICAN:VNRX) said that it is forming a Texas-based subsidiary called Volition Veterinary Diagnostics Development LLC and is tapping animal health expert Nathan Dewsbury to spearhead it. The company is working with Texas A&M University’s College of Veterinary Medicine to conduct a study of Nu.Q Vet, a key target market for early revenue given the simpler regulatory pathway for veterinary products. Volition's NuQ diagnostic blood tests pinpoints irregular levels of nucleosomes in the blood, which indicate cancer. The company aims to have the first Nu.Q Vet product on the market in the United States in 2020.

Propanc Biopharma Inc (OTCMKTS:PPCB) is gearing up for a first-in-human trial of its metastatic cancer treatment, and has just completed a crucial step: quantifying the active ingredients. The drug candidate, PRP is a mix of two proenzymes that targets solid cancerous tumors. This step is crucial in developing the drug at scale and determining dosing, and its completion allows Propanc to move forward in discussions with potential sites for its clinical trial, which the company expects to launch in early 2020.

Global Energy Metals Corp (CVE:GEMC) (OTCMKTS:GBLEF) has unveiled promising findings from its work to identify drill targets at the Lovelock cobalt mine project in Nevada and believes the site offers 'superb' potential to create value. The firm is aiming to create a property-wide geological model, which will be key to a drill program, earmarked for the fourth quarter of this year. GEMC said a bulk sample taken by Canada Cobalt Works from waste rock in the historic dumps in front of the mine openings had undergone initial analysis resulting in assays of 0.2% cobalt, 0.19% nickel and 2.84% copper.

Globex Mining Enterprises Inc (TSE:GMX) (OTCMKTS:GLBXF) partner Chibougamau Independent Mines Inc (CVE:CBG) reported Thursday that two additional sets of assays have been received from drill hole BJ-19-22 at the Bateman Bay, C-3 copper/gold property in Quebec, Canada. Chibougamau said an additional copper/gold zone, 11.6 m below Wednesday’s reported intersection, returned 1.66% copper, 2.01 g/t silver, 5.7 g/t gold and 0.02% cobalt over 11 m for a true width of 3.70 m.

Roth Capital reckons miner Gold Resource Corporation (NYSEAMERICAN:GORO) is due a re-rating with production and cashflow set to continue to increase in the second half as commercial output is achieved at its Isabella Pearl mine in Nevada. In a note published on Thursday, the broker repeated a Buy rating on the stock, with a target price of $6.50.

The Flowr Corporation (CVE:FLWR) (OTCQB:FLWPF) said it has closed its previously announced bought deal financing, raising aggregate gross proceeds of $43,501,000 with the issue of a total of 10,610,000 offered units, consisting of one common share and one half of one common share purchase warrant, at a price of $4.10 each. The company has also granted the underwriters an Over-Allotment Option which, if exercised in full, means the aggregate gross proceeds of the offering will be $50,026,150. The group said the net proceeds are expected to be used to fund, in part, Flowr’s acquisition of the approximately 80% equity interest of Holigen Holdings Limited, that it does not already own, working capital required for the construction and development of certain of Holigen’s and the company’s cultivation and production facilities, and for general corporate purposes.

Hemispherx Biopharma Inc (NYSEAMERICAN:HEB) stock flew in premarket trade Thursday after it issued a final report on its phase 1 trial supporting the safety of using its flagship drug Ampligen as a combination therapy with Intron A and Celecoxib for treating recurrent ovarian cancer. In a statement, the company said the research team, led by Dr Robert Edwards, Anda Vlad and Brian Orr, found that Ampligen was “well tolerated” as a combination therapy.

NexTech AR Solutions Corp (CSE:NTAR) (OTCMKTS:NEXCF) is teaming up with Budweiser to run a social media sweepstakes using its augmented reality technology.  The iconic beer brand is giving away season tickets to the Budweiser Stage, an entertainment venue in Toronto, to celebrate its 25th anniversary.

Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) subsidiary Empower Healthcare Corp has received its hemp-handlers license in Oregon, the company announced Thursday. The company can now move forward with the operation and expansion of its 5,000 square-foot extraction facility in the state. Empower has also applied for a Food Establishment Plan permit, which would allow the company to produce edible products like CBD gummies, beverages, chocolate or baked goods.

CytoDyn Inc (OTCMKTS:CYDY) revealed Thursday that it has filed a Phase 2 protocol with the US Food and Drug Administration for a combination therapy of leronlimab and regorafenib to treat patients with metastatic colorectal cancer.  The late-stage biotechnology company said the study will be conducted by lead principal investigator John L Marshall, who is an expert in drug development for colon cancer. He is also the chief of the Division of Hematology-Oncology at MedStar Georgetown University Hospital, in Washington.

Codebase Ventures Inc. (CSE:CODE) ) (OTCQB:BKLLF) (FSE:C5B) has updated investors on the focus of the company’s cannabis industry subsidiary as management explores early stage opportunities in the UK and European cannabinoid (CBD) and medicinal cannabis markets. DD in May.

LexaGene Holdings Inc (CVE:LXG) (OTCMKTS:LXXGF) is teaming up with Assurance Scientific Laboratories (ASL) to test its rapid pathogen detection technology on urine samples. The beta testing will focus on detecting pathogens which cause the urinary tract infections while also screening for genetic markers of antimicrobial resistance. ASL will use LexaGene’s open access to compare its pathogen detection and antimicrobial resistance characterization technology to ASL’s own.

Nano One Materials Corp (CVE:NNO) (OTCMKTS:NNOMF) reported a further boost to its technology and business plan Thursday as the company said it had received another key US patent. Amid the frenzy to commercialize lithium-ion batteries in electric vehicles, the tech group is advancing a lithium nickel manganese cobalt (NMC) cathode technology. The process can produce low-cost, high performance lithium ion battery cathode materials.

CROP Infrastructure Corp (CSE:CROP) (OTCMKTS:CRXPF) told investors Thursday it was now seeing cash flow from its California farm's harvest in 2018 as it updated on orders. CROP said the California farm had received and executed the first order from its 2018 harvest amounting to US$41,625 in whole flower. Meanwhile, its tenanted Washington facility sold US$83,749 in newly harvested flower. Both deals were in the first week of August this year.

Blackrock Gold Corp (CVE:BRC) is getting set to drill its Silver Cloud property after receiving the necessary permits from Nevada authorities. The exploration company announced Thursday that the Bureau of Land Management approved its proposed core drill program at Silver Cloud, located in Elko County. The permits authorize Vancouver-based Blackrock to drill the Silver Cloud mercury mine and Northwest Canyon area and a newly discovered vein target.

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) said Thursday it has completed its collaboration with the Canada’s national research body that led to exciting new findings for the company’s patented DehydraTECH technology. The primary goal of the research and development program with the National Research Council of Canada was to find out whether DehydraTECH caused new molecular entities (NME) through its processing.

Great Panther Mining Limited (NYSEAMERICAN:GPL) (TSX:GPR) said it has closed its bought deal financing. raising aggregate gross proceeds of US$17,250,000 through the issue of 23,000,000 common shares of the company at the price of US$0.75 each. The group said the underwriters fully exercised their over-allotment option to purchase 3,000,000 Shares and received a cash commission equal to 5% of the gross proceeds of the offering. It added that participation in the offering by insiders and company employees totaled approximately US$0.6 million.  Jeffrey Mason, Great Panther’s chairman commented: "The completion of the financing provides us with the immediate capital to continue to grow the Company as an intermediate gold and silver producer.  We thank our existing and new shareholders, employees and board members who participated."

Mandalay Resources Corp's (TSE:MND) (OTCMKTS:MNDJF) said on Wednesday that it saw a strengthening in its finances in the second quarter, as production at its Swedish mine, Björkdal saw notable operational optimization and improvement.  The company has producing mines at Björkdal, Sweden and in Costerfield, Australia.

Kincora Copper Ltd (CVE:KCC)  announced Wednesday that the TSX Venture Exchange has accepted for filing the company's proposal to issue 1,037,376 bonus shares to designated insider, Sam Spring  in consideration of services rendered over 24 months.

Duos Technologies Group, Inc  (OTCQX:DUOT), a provider of intelligent analytical technology solutions, will hold a conference call on Wednesday, August 14, 2019 at 5:00 pm Eastern time to discuss its’ financial results for the second quarter ended June 30, 2019.

Bioporto A/S (CPH:BIOPOR), the Danish diagnostics specialist said, in connection with the release of its Q2 2019 report, the group will hold an investor meeting on August 15, 2019 at 3 pm at Tuborg Havnevej 15, st., 2900 Hellerup, Copenhagen.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of AIM ImmunoTech Inc. named herein, including the promotion by the Company of AIM ImmunoTech Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Arcadian CEO says Cannabis is still a good bet

Arcadian CEO and Founder Matthew J Nordgren sat down at the MJ Micro Conference with Proactive's Steve Darling to discuss the state of the cannabis industry. Nordgren telling Proactive he feels the cannabis industry still has huge upside and he feels the future looks very bright.

16 minutes ago

12 min read